Drug development veteran Dr. Steve Chen joins as Chief Medical Officer Biopharma finance expert Mr. Jason Ding joins as Chief Business Officer EDMONTON, Alberta--(BUSINESS WIRE)--Entos Pharmaceuticals (Entos), a clinical-stage biotechnology company deve
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: CRSWF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous tryptamines (biomolecules acting as psychoneuroplastogens
Follows U.S. approval for relapsed or refractory marginal zone lymphoma in 2021 Third approved indication for BRUKINSA in Canada, following mantle cell lymphoma (MCL) and Waldenström’s macroglobulinemia (WM) MISSISSAUGA, Ontario & CAMBRIDGE, Mass. &
AYLMER, Ontario--(BUSINESS WIRE)--#canadiancannabis--Motif Labs is pleased to announce a new service offering to its existing operations, with the addition of a dedicated production line for infused pre-roll products. Available to Licensed Producers (LP
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 3, 2021 to its short form base shelf prospectus dated April 22, 2021. CALGARY, Alberta--(BUSINESS WIRE)--High Tide Inc.
Mr. Havis will Lead Commercialization from Europe to Asia YOKNEAM, Israel & MIAMI--(BUSINESS WIRE)--#COMANECI--Rapid Medical, a leading developer of neurovascular devices, announces the promotion of Eitan Havis to President, International. Mr. Havis will
Public formulary and program coverage makes AJOVY® accessible to more migraine patients across Canada MONTRÉAL--(BUSINESS WIRE)--Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., welcomes the recently announced public formulary
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM” is pleased to announce that Doug Drysdale, Cybin’s Chief Exe
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and dev
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical p
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.